MA11.02 Targeting HER2 Exon 20–Mutant Lung Adenocarcinoma with a Novel Tyrosine Kinase Inhibitor, Mobocertinib

Autor: Han, H., Li, S., Chen, T., Fitzgerald, M., Liu, S., Peng, C., Tang, K., Cao, S., Chouitar, J., Wu, J., Peng, D., Deng, J., Gao, Z., Baker, T., Li, F., Zhang, H., Pan, Y., Ding, H., Hu, H., Pyon, V., Thakurdin, C., Papadopoulos, E., Tang, S., Gonzalvez, F., Chen, H., Rivera, V., Brake, R., Vincent, S., Wong, K.
Zdroj: In Journal of Thoracic Oncology October 2021 16(10) Supplement:S918-S918
Databáze: ScienceDirect